Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Skinvisible (SKVI) EBT Margin (2016 - 2025)

Historic EBT Margin for Skinvisible (SKVI) over the last 17 years, with Q3 2025 value amounting to 5004.9%.

  • Skinvisible's EBT Margin rose 8496200.0% to 5004.9% in Q3 2025 from the same period last year, while for Sep 2025 it was 5888.06%, marking a year-over-year increase of 915200.0%. This contributed to the annual value of 6295.14% for FY2024, which is 55924900.0% up from last year.
  • Skinvisible's EBT Margin amounted to 5004.9% in Q3 2025, which was up 8496200.0% from 5579.14% recorded in Q2 2025.
  • Skinvisible's EBT Margin's 5-year high stood at 51.75% during Q2 2021, with a 5-year trough of 30240.36% in Q1 2023.
  • For the 5-year period, Skinvisible's EBT Margin averaged around 5573.8%, with its median value being 5606.9% (2023).
  • As far as peak fluctuations go, Skinvisible's EBT Margin crashed by -296249700bps in 2023, and later soared by 244485200bps in 2024.
  • Skinvisible's EBT Margin (Quarter) stood at 70.91% in 2021, then tumbled by -11433bps to 8177.86% in 2022, then increased by 26bps to 6085.9% in 2023, then dropped by -21bps to 7348.12% in 2024, then surged by 32bps to 5004.9% in 2025.
  • Its EBT Margin stands at 5004.9% for Q3 2025, versus 5579.14% for Q2 2025 and 5620.1% for Q1 2025.